Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NIAID

ISOLATED EPSTEIN-BARR VIRUS BZLF2 PROTEINS THAT BIND MHC CLASS II BETA CHAINS

  • Read more about ISOLATED EPSTEIN-BARR VIRUS BZLF2 PROTEINS THAT BIND MHC CLASS II BETA CHAINS
US Patent 5,726,286
Filed on 1996-04-28

HIV-1 THERAPY WITH IL-2 AND ANTI-TNF ANTIBODY

  • Read more about HIV-1 THERAPY WITH IL-2 AND ANTI-TNF ANTIBODY
US Application 08/716,107
Filed on 1996-09-19

METHODS FOR ENHANCING ORAL TOLERANCE AND TREATING AUTOIMMUNE DISEASE USING INHIBITORS OF INTERLEUKIN-12

  • Read more about METHODS FOR ENHANCING ORAL TOLERANCE AND TREATING AUTOIMMUNE DISEASE USING INHIBITORS OF INTERLEUKIN-12
Patent Cooperation Treaty
PCT/US1996/016007
Filed on 1996-10-11

CLONING AND EXPRESSION OF DNA INVOLVED IN THE BIOSYNTHESIS OF CYCLOPROPANATED MYCOLIC ACIDS IN MYCOBACTERIUM TUBERCULOSIS

  • Read more about CLONING AND EXPRESSION OF DNA INVOLVED IN THE BIOSYNTHESIS OF CYCLOPROPANATED MYCOLIC ACIDS IN MYCOBACTERIUM TUBERCULOSIS
US Application 08/807,787
Filed on 1997-02-28

MODIFIED PROTEOLIPID PROTEIN MOLECULES

  • Read more about MODIFIED PROTEOLIPID PROTEIN MOLECULES
US Application 08/482,114
Filed on 1995-06-07

MODIFIED PROTEOLIPID PROTEIN MOLECULES

  • Read more about MODIFIED PROTEOLIPID PROTEIN MOLECULES
US Application 08/431,648
Filed on 1995-05-02

HEPATITIS A VIRUS VACCINES

  • Read more about HEPATITIS A VIRUS VACCINES
US Patent 6,113,912
Filed on 1995-06-07

Mixing Arrangement and Method

  • Read more about Mixing Arrangement and Method
US Patent 5,810,773
Filed on 1997-03-25

INTERLEUKIN-2 STIMULATED T LYMPHOCYTE CELL DEATH FOR THE TREATMENT OF AUTOIMMUNE DISEASES, ALLERGIC DISORDERS, AND GRAFT REJECTION

  • Read more about INTERLEUKIN-2 STIMULATED T LYMPHOCYTE CELL DEATH FOR THE TREATMENT OF AUTOIMMUNE DISEASES, ALLERGIC DISORDERS, AND GRAFT REJECTION
Patent Cooperation Treaty
PCT/US1993/005481
Filed on 1993-06-09

ATTENUATED RESPIRATORY SYNCYTIAL VIRUS VACCINE COMPOSITIONS

  • Read more about ATTENUATED RESPIRATORY SYNCYTIAL VIRUS VACCINE COMPOSITIONS
US Patent 6,284,254
Filed on 1995-05-30

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 559
  • Page 560
  • Page 561
  • Page 562
  • Page 563
  • Page 564
  • Page 565
  • Page 566
  • Page 567
  • …
  • Next page ››
  • Last page Last »
Subscribe to NIAID
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health